Addvise logo
sv_SE
sv_SE
search

ADDvise Group’s reporting dates 2021

13-10-2020   Regulatory press release

Year-end report 2020 (Jan-Dec)                                     2021-02-25

Last day for shareholders to request                              2021-03-05
an item to be included to the agenda
of the Annual General Meeting

Annual General Meeting                                                 2021-04-23

Three-month report (Jan-March)                                    2021-04-23

Six-month report (Jan-Jun)                                             2021-07-23

Nine-month report (Jan-Sep)                                          2021-10-27

Year-end report 2021 (Jan-Dec)                                     2022-02-24

 

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

    

Latest press releases

Year-end report 2022, January 1-December 31

Regulatory

October–December 2022 Net revenue for the period was SEK 320.3 million (155.0), an increase of 106.6 %. Organic growth was 5.5 %. Orders received for the period was SEK 517.7 million (177.6), an increase of 191.5 %. Organic growth was 7.7 %. Adjusted EBITDA for the period was SEK 85.8 million (19.0) EBITDA for the…

ADDvise presents financial targets for 2023

Regulatory

The Board of Directors of ADDvise Group has adopted financial targets for the financial year 2023: -          Net sales pro forma rolling 12 months shall by the end of the year reach SEK 1.6 billion. -          EBITDA pro forma rolling 12 months shall by the end of the year reach SEK 330 million. The below…

ADDvise signs Letter of Intent to acquire Diabetic Supplies Inc.

Regulatory

ADDvise Group has signed a Letter of Intent with the shareholder of Diabetic Supplies Inc. (”Diabetic Supplies” or the “Company”) regarding an acquisition of all shares in Diabetic Supplies. Diabetic Supplies is based in Columbus, Ohio, USA and is a distributor of medical devices for diabetic patients. The Company distributes, among other things, continuous glucose…